Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients
ClinicalTrials.gov study NCT05802992. IPD Sharing: NO. Countries: 1. Publications: 7.
Thrombosis in Patients With Multiple Myeloma in an University Medical Center
ClinicalTrials.gov study NCT05541978. IPD Sharing: Not stated. Countries: 1. Publications: 17.
Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT04063189. IPD Sharing: UNDECIDED. Countries: 1. Publications: 12.
A Phase 1/2 Study of a Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma (FUMANBA-1)
ClinicalTrials.gov study NCT05066646. IPD Sharing: NO. Countries: 1. Publications: 2.
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Tran
ClinicalTrials.gov study NCT05561751. IPD Sharing: NO. Countries: 1. Publications: 1.
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
ClinicalTrials.gov study NCT01454297. IPD Sharing: YES. Countries: 3. Publications: 4.
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04586426. IPD Sharing: YES. Countries: 7. Publications: 3.
An Intensive Program With Quadruplet Induction and Consolidation Plus Tandem Autologous Stem Cell Transplantation in Newly Diagnosed High Risk Multiple Myeloma Patients
ClinicalTrials.gov study NCT03606577. IPD Sharing: NO. Countries: 1. Publications: 2.
Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
ClinicalTrials.gov study NCT00772811. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03399799. IPD Sharing: Not stated. Countries: 4. Publications: 7.
Genomic-Based Diagnosis, Classification and Targeted Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT01619358. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Multiple Myeloma and Environmental Exposure to Pesticides in the French West Indies: A Population Based Case-control Study.
ClinicalTrials.gov study NCT04260490. IPD Sharing: NO. Countries: 2. Publications: 2.
Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON)
ClinicalTrials.gov study NCT01325896. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
ClinicalTrials.gov study NCT05199311. IPD Sharing: Not stated. Countries: 1. Publications: 77.
NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01521533. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy
ClinicalTrials.gov study NCT07026799. IPD Sharing: YES. Countries: 1. Publications: 5.
RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00729638. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)
ClinicalTrials.gov study NCT02036502. IPD Sharing: YES. Countries: 0. Publications: 1.
Optical Genome Mapping in Characterization of Multiple Myeloma
ClinicalTrials.gov study NCT05786105. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)
ClinicalTrials.gov study NCT03748953. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.